PineTree Therapeutics

company

About

PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$23.50M
Industries
Biotechnology,Medical,Therapeutics,Wellness
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active

PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$23.50M
PineTree Therapeutics has raised a total of $23.50M in funding over 2 rounds. Their latest funding was raised on Jun 7, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 7, 2022 Series A $23.50M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
PineTree Therapeutics is funded by 2 investors. SGI Venture Capital and JCurve Investment are the most recent investors.
Investor Name Lead Investor Funding Round
SGI Venture Capital Series A
JCurve Investment Series A